Search For Lab Tests Here

The Glucose Test measures blood sugar levels to evaluate energy metabolism and screen for diabetes or prediabetes. Abnormal glucose may indicate hyperglycemia, hypoglycemia, or metabolic disorders. Doctors use this test during routine exams, to investigate symptoms like fatigue, excessive thirst, or frequent urination, and to monitor treatment for diabetes. It provides essential insight into how the body regulates blood sugar and overall metabolic health.

The Glucose Tolerance Test, 5 Specimens evaluates glucose response at fasting, 1, 2, 3, and 4 hours after a standard glucose drink. By analyzing multiple specimens, it identifies impaired glucose tolerance, prediabetes, and type 2 diabetes. The test provides clinicians with extensive information on insulin function, glucose regulation, and the progression of metabolic disorders that affect long-term health outcomes.

The Glucose Tolerance Test, 3 Specimens, 75g evaluates blood sugar at fasting, 1-hour, and 2-hour intervals following a 75-gram glucose drink. It is a key diagnostic tool for identifying impaired glucose regulation, prediabetes, and type 2 diabetes. Measuring glucose response at multiple times allows clinicians to assess insulin function, detect early metabolic dysfunction, and better understand progression to diabetes.

The Glucose Tolerance Test, 7 Specimens evaluates blood sugar at fasting and six hourly intervals after ingestion of a glucose solution, spanning 6 hours of monitoring. It is used to identify prediabetes, diabetes, and impaired glucose regulation. By analyzing seven specimens, the test reveals patterns in insulin function, metabolic regulation, and progression of abnormalities that impact long-term health.

The Glucose Tolerance Test, 2 Specimens, 75g evaluates the body’s glucose metabolism by testing fasting and one-hour blood glucose levels after ingestion of a 75-gram glucose solution. It is an important diagnostic tool for identifying impaired glucose regulation, prediabetes, and type 2 diabetes. This test helps reveal early changes in insulin sensitivity and overall metabolic function.

The Glucose Tolerance Test, 4 Specimens evaluates blood glucose at fasting, 1-hour, 2-hour, and 3-hour intervals after a glucose drink. This test is an important tool for diagnosing or screening for prediabetes, type 2 diabetes, and impaired glucose metabolism. Measuring glucose response across multiple specimens provides valuable data on insulin function, carbohydrate handling, and overall metabolic health.

The Glucose Tolerance Test, 6 Specimens evaluates blood sugar response at fasting and hourly intervals up to 5 hours after ingestion of a glucose solution. This test provides a comprehensive assessment of glucose metabolism, helping detect impaired glucose tolerance, prediabetes, and diabetes risk. Measuring six specimens reveals detailed patterns of insulin function, metabolic regulation, and progression to chronic disease.

The Glucose Plasma Test measures the amount of glucose in the blood to assess how the body regulates sugar. Abnormal results may indicate diabetes, prediabetes, hypoglycemia, or other metabolic disorders. Doctors order this test for patients with symptoms like fatigue, excessive thirst, or frequent urination. It is also commonly used for routine health screening, monitoring diabetes treatment, and guiding lifestyle or medication adjustments.

The Glucose Random Test evaluates glucose levels in the blood without requiring fasting, making it useful for detecting abnormal sugar regulation. Elevated or low results may suggest diabetes, prediabetes, or hypoglycemia. This test supports assessment of metabolic function, carbohydrate processing, and systemic health, offering insight into symptoms like thirst, frequent urination, or unexplained fatigue.

The Cardio IQ® Glucose test is a specialized diagnostic test designed to assess blood glucose levels with high precision and accuracy. This test is used to evaluate an individual's metabolic health by measuring glucose concentrations in the blood, providing insight into carbohydrate metabolism, insulin function, and overall glycemic control. Maintaining stable glucose levels is crucial for energy production, cellular function, and preventing metabolic disorders. The Cardio IQ® Glucose test is particularly valuable in assessing the risk of diabetes, prediabetes, insulin resistance, and other metabolic conditions that impact cardiovascular health.

 The 1 Hour Fasting and Postprandial Glucose test is a two-part diagnostic evaluation that first measures the glucose level in the blood after an overnight fast and then assesses it again one hour after consuming a glucose-rich meal or drink.

 The 2 Hour Fasting and Postprandial Glucose Test is a diagnostic procedure that measures the body's ability to metabolize glucose (sugar) and respond to insulin. It involves taking two blood samples: one after an overnight fast and another two hours after consuming a meal.

The Hemoglobin A1c with Calculated Mean Plasma Glucose Test measures average blood sugar over 2–3 months and provides an estimated mean plasma glucose (eAG). Elevated A1c may indicate diabetes or poor glucose control, while normal results reflect healthy management. Doctors use this test to diagnose diabetes, assess long-term control, and adjust treatment. Results give valuable insight into glycemic control, reducing risk of complications like kidney, eye, and heart disease.

The Insulin Response to Glucose Test, 6 Specimens evaluates insulin secretion and glucose regulation with fasting and five post-glucose solution samples. This comprehensive approach highlights beta-cell activity, insulin resistance, and abnormalities in carbohydrate metabolism. Results show how efficiently the body clears glucose, supporting early detection of metabolic dysfunction, prediabetes, and diabetes risk.

The Gestational Glucose Screen, 50g, 135 Cutoff evaluates maternal blood sugar one hour after a 50-gram glucose drink to screen for gestational diabetes risk. A threshold of 135 mg/dL helps determine the need for follow-up glucose tolerance testing. This test offers important information on maternal carbohydrate metabolism, insulin function, and potential complications related to abnormal glucose regulation in pregnancy.

The Insulin Response to Glucose Test, 3 Specimens evaluates insulin secretion at three time points: fasting and after drinking a glucose solution at set intervals. This approach helps identify abnormal insulin sensitivity, altered beta-cell activity, and impaired carbohydrate metabolism. Results provide essential information about how efficiently the body regulates glucose, supporting early detection of insulin resistance or diabetes risk.

The Fasting and Gestational Glucose Test, 135 Cutoff evaluates fasting glucose and post-load blood sugar one hour after a 50-gram glucose challenge. A 135 mg/dL cutoff helps identify women at increased risk for gestational diabetes who may require follow-up testing. This test offers valuable information about maternal carbohydrate metabolism, insulin activity, and abnormal glucose regulation in pregnancy.

The Insulin Response to Glucose Test, 2 Specimens evaluates insulin secretion by comparing fasting levels with those measured after drinking a glucose solution. This test helps identify impaired insulin sensitivity, abnormal glucose regulation, and early metabolic dysfunction. It provides valuable information on beta-cell function, carbohydrate metabolism, and risk of developing prediabetes or diabetes.

The Gestational Glucose Screen, 50g, 140 Cutoff evaluates blood glucose one hour after a 50-gram glucose drink to screen for gestational diabetes risk. The 140 mg/dL threshold identifies women who may need follow-up testing with an oral glucose tolerance test. This screening tool provides insight into maternal carbohydrate metabolism, insulin function, and potential pregnancy-related health concerns.

The Insulin Response to Glucose Test, 4 Specimens evaluates insulin secretion and glucose regulation using fasting and three post-glucose solution samples. This expanded view highlights beta-cell activity, insulin resistance, and abnormal carbohydrate metabolism. Results reveal how efficiently the body processes glucose and help identify metabolic dysfunction, prediabetes, and diabetes-related risks.

The Insulin Response to Glucose Test, 5 Specimens evaluates insulin secretion at fasting and multiple post-glucose solution intervals. This expanded assessment highlights beta-cell function, insulin sensitivity, and abnormalities in carbohydrate metabolism. Results offer valuable information on how the body clears glucose and help identify insulin resistance, metabolic dysfunction, and diabetes-related risks.

The C-Peptide Response to Glucose Test with 2 specimens evaluates pancreatic beta cell activity and insulin secretion during glucose intake. By measuring changes in C-peptide levels at two time points, it helps assess insulin production, glucose regulation, and potential insulin resistance or diabetes-related disorders. This test offers insight into metabolic health and endocrine function.

The C-Peptide Response to Glucose Test with 5 specimens measures pancreatic beta cell activity and insulin secretion across five timed intervals. Tracking C-peptide levels over multiple points provides detailed insight into glucose regulation, insulin resistance, hypoglycemia, and diabetes risk, supporting evaluation of metabolic balance and overall endocrine health.

The Insulin and Glucose panel is a focused diagnostic tool used to evaluate blood sugar levels and insulin, the hormone responsible for regulating glucose uptake from the bloodstream into the cells. This panel includes two essential tests: one for measuring glucose levels and another for assessing insulin levels in the blood. Together, these tests provide valuable insights into the body's glucose metabolism and insulin function, which are crucial for diagnosing and managing diabetes and other metabolic disorders.

The Gestational Glucose Tolerance Test, 3 Specimens, 75g evaluates glucose metabolism during pregnancy by testing fasting, 1-hour, and 2-hour blood glucose following a 75-gram glucose solution. It is widely used to diagnose gestational diabetes and assess maternal insulin function. Monitoring three intervals provides clinicians with essential information about pregnancy-related metabolic health and risk factors.